Additionally, patients with inflammatory bowel disease, severe gastroesophageal reflux disease, or other significant gastrointestinal disorders should be monitored closely if treatment is initiated, as the gastrointestinal effects of semaglutide may worsen their underlying condition
A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used to treat obesity
Youtheorys new supplement line offers an innovative solution for those looking to maintain their strength, vitality, and overall well-being throughout their weight loss journey
doi: 10.1016/j.jhep.2022.04.003 103 LinLXuXYuYYeHHeXChenSet al
Setting realistic expectations from the start helps prevent the frustration and disappointment that lead to premature discontinuation
The relatively mild ultrastructural abnormalities of the collagen fibrils of the dermis reported here, in both mildly (P2, P5) and more severely affected (P3-P4) patients, warn against relying too heavily on TEM